BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36662668)

  • 1. The human and animals' malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans.
    Pinto C; Aluai-Cunha C; Santos A
    Melanoma Res; 2023 Apr; 33(2):87-103. PubMed ID: 36662668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneously occurring melanoma in animals and their relevance to human melanoma.
    van der Weyden L; Brenn T; Patton EE; Wood GA; Adams DJ
    J Pathol; 2020 Sep; 252(1):4-21. PubMed ID: 32652526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison.
    Prouteau A; André C
    Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31262050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.
    Hernandez B; Adissu HA; Wei BR; Michael HT; Merlino G; Simpson RM
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.
    Simpson RM; Bastian BC; Michael HT; Webster JD; Prasad ML; Conway CM; Prieto VM; Gary JM; Goldschmidt MH; Esplin DG; Smedley RC; Piris A; Meuten DJ; Kiupel M; Lee CC; Ward JM; Dwyer JE; Davis BJ; Anver MR; Molinolo AA; Hoover SB; Rodriguez-Canales J; Hewitt SM
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):37-47. PubMed ID: 24128326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology.
    Segaoula Z; Primot A; Lepretre F; Hedan B; Bouchaert E; Minier K; Marescaux L; Serres F; Galiègue-Zouitina S; André C; Quesnel B; Thuru X; Tierny D
    BMC Cancer; 2018 Dec; 18(1):1219. PubMed ID: 30514258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunology and canine malignant melanoma: A comparative review.
    Atherton MJ; Morris JS; McDermott MR; Lichty BD
    Vet Immunol Immunopathol; 2016 Jan; 169():15-26. PubMed ID: 26827834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.
    Barutello G; Rolih V; Arigoni M; Tarone L; Conti L; Quaglino E; Buracco P; Cavallo F; Riccardo F
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative review of melanocytic neoplasms.
    Smith SH; Goldschmidt MH; McManus PM
    Vet Pathol; 2002 Nov; 39(6):651-78. PubMed ID: 12450197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
    Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
    Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas.
    Gillard M; Cadieu E; De Brito C; Abadie J; Vergier B; Devauchelle P; Degorce F; Dréano S; Primot A; Dorso L; Lagadic M; Galibert F; Hédan B; Galibert MD; André C
    Pigment Cell Melanoma Res; 2014 Jan; 27(1):90-102. PubMed ID: 24112648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiome and melanoma: A review.
    Makaranka S; Scutt F; Frixou M; Wensley KE; Sharma R; Greenhowe J
    Exp Dermatol; 2022 Sep; 31(9):1292-1301. PubMed ID: 35793428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncolytic effects of reovirus in canine solid tumor cell lines.
    Igase M; Hwang CC; Coffey M; Okuda M; Noguchi S; Mizuno T
    J Vet Med Sci; 2015 May; 77(5):541-8. PubMed ID: 25648933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.
    Alexander AN; Huelsmeyer MK; Mitzey A; Dubielzig RR; Kurzman ID; Macewen EG; Vail DM
    Cancer Immunol Immunother; 2006 Apr; 55(4):433-42. PubMed ID: 15965647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light and electron microscopic study of the large pale cell in a canine malignant melanoma.
    Turk JR; Leathers CW
    Vet Pathol; 1981 Nov; 18(6):829-32. PubMed ID: 7292898
    [No Abstract]   [Full Text] [Related]  

  • 16. Canine oral melanoma.
    Bergman PJ
    Clin Tech Small Anim Pract; 2007 May; 22(2):55-60. PubMed ID: 17591290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
    Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
    BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine melanoma: a comparison with human pigmented epithelioid melanocytoma.
    Liu W; Bennett M; Helm T
    Int J Dermatol; 2011 Dec; 50(12):1542-5. PubMed ID: 22098004
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.
    Koenig A; Bianco SR; Fosmire S; Wojcieszyn J; Modiano JF
    Vet Pathol; 2002 Jul; 39(4):458-72. PubMed ID: 12126149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic malignant melanoma adenocarcinoma in the digit of a dog.
    Needle DB; Iglikova O; Miller AD
    J Vet Diagn Invest; 2018 Mar; 30(2):315-318. PubMed ID: 29284381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.